fbpx
May 4, 2020

Onc Daily: Center to Pay $100M Penalty, Blood Test Aids Detection Onc Daily: Center to Pay $100M Penalty, Blood Test Aids Detection

Here are the most important stories that Medscape Oncology’s editors picked for you to read today. Cancer Center Pays $100 Million Antitrust Penalty A high-profile oncology […]
May 4, 2020

Students Upset by USMLE Response to COVID-19 Demand Changes Students Upset by USMLE Response to COVID-19 Demand Changes

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Students frustrated with changes to the way they will take US Medical […]
May 1, 2020

EMA Panel Backs Generic for MS Drug Fingolimod (Gilenya) EMA Panel Backs Generic for MS Drug Fingolimod (Gilenya)

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of a generic version of fingolimod (Gilenya, Novartis) […]
May 1, 2020

EU Panel OKs Glasdegib for AML & Luspatercept for MDS EU Panel OKs Glasdegib for AML & Luspatercept for MDS

A new drug for acute myeloid leukemia (AML), glasdegib (Daurismo, Pfizer). is approaching approval in Europe. The drug was approved in the United States in November […]
April 28, 2020

Onc Daily: Cancer Care Upended by COVID-19, Preventable Deaths Onc Daily: Cancer Care Upended by COVID-19, Preventable Deaths

Here are the most important stories that Medscape Oncology’s editors picked for you to read today: Cancer Care Upended During COVID-19 The whole pathway of cancer […]
April 28, 2020

FDA Clears Opicapone (Ongentys) as Add-On Therapy in PD FDA Clears Opicapone (Ongentys) as Add-On Therapy in PD

The US Food and Drug Administration (FDA) has approved opicapone (Ongentys, Neurocrine Biosciences) as add-on therapy for patients with Parkinson disease who experience “off” periods while […]
April 28, 2020

New Advocacy Group Aims to Give ‘Every Physician’ a Voice New Advocacy Group Aims to Give ‘Every Physician’ a Voice

A new advocacy organization is launching today to give “every physician” a voice in decisions that affect their professional lives. But this group doesn’t intend to […]
April 24, 2020

FDA Warns Against Hydroxychloroquine Use Outside of Hospital FDA Warns Against Hydroxychloroquine Use Outside of Hospital

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The U.S. Food and Drug Administration reinforced its March guidance on when […]
April 22, 2020

FDA OKs New Drug for Triple-Negative Breast Cancer FDA OKs New Drug for Triple-Negative Breast Cancer

The US Food and Drug Administration (FDA) granted accelerated approval to sacituzumab govitecan (Trodelvy, Immunomedics) for the treatment of metastatic triple-negative breast cancer (TNBC). Eligible patients […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0